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Summary
Intedeukin (IL) 2-deficient mice develop a fatal immunopathology characterized by lymph-
adenopathy, splenomegaly, T cell infiltration of the bone marrow, loss of B cells, anemia, and
inflammation of the gut. The thymus dependence of these disease symptoms was tested by in-
troducing the IL-2 mutation into athymic mice. With the exception of an increase in CD8+
intrahepatic oLlp T cells, IL-2 deficiency had no detectable effect on leukocyte composition or
health of athymic mice, indicating a key role for thymus-derived T cells in the initiation of dis-
ease and demonstrating that B cell development and survival are independent of IL-2. In adop-
tive transfer studies, lymph node and spleen cells from euthymic IL-2-deficient mice induced
disease in athymic mice with an intact IL-2 gene, suggesting that thymus-independent IL-2-
expressing cells are unable to control the development of immune pathology. Both IL-2+ and
IL-2 -' - bone marrow cells repopulated the thymus and the peripheral T cell compartment of
the recombination activator gene 2-deficient recipients, and chimeras that had received IL-2-
deficient bone marrow developed immune pathology. Disease development was, however, fully
or at leastpartially prevented when 30% ofthe bone marrow inoculum was derived from mice
able to express IL-2. These results demonstrate that the IL-2 deficiency syndrome depends on
the intrathymic differentiation ofT cells carrying the IL-2 mutation, and that the abnormal acti-
vation of IL-2-deficient lymphocytes can be controlled by thymus-derived but not thymus-
independent lymphocytes.
I
L-2, originally described as T cell growth factor, has
pleiotropic effects on the proliferation and differentiation
ofT, B, and NK cells. In addition, inhibition of T cell de-
velopment by antibodies to the of chain of the IL-2 receptor
(IL-2R) reported by some (1, 2) but not by other investiga-
tors (3) had suggested an essential role for IL-2 in intrathy-
mic T cell maturation. Unexpectedly, however, mainstream
T cell development in mice with a disrupted IL-2 gene is
normal (4), and after 3-4 wk of age, peripheral T cells are
even increased in number and display an activated pheno-
type. This marks the onset of a lethal syndrome character-
ized by splenomegaly and lymphadenopathy, an early burst
ofB cell activation followed by their virtual disappearance,
T cell infiltration of the bone marrow, anemia, autoanti-
body production, and a severe colitis preceded by an infil-
tration of the gut epithelium with CD4 and CD8 ot/(3 T
cells (5-8) . Hyperactivation of T cells and development of
autoimmunity have also been observed in mice lacking the
IL-2R/3 chain (9), supporting the concept that IL-2R-
mediated signals are required for the containment of T cell
activation in vivo. Among the mechanisms that could lead
to the development ofthe symptoms listed above are an in-
complete deletion of autoreactive clones in T cell ontog-
eny, unchecked lymphocyte activation caused by a distur-
bance of the cytokine network, physical or functional
absence of specialized suppressor cells, and a requirement
for IL-2 in limiting clonal growth by predisposing mature
activated T cells toward apoptotic death (10) . In addition,
breakdown of the B cell compartment could either result
from T cell-mediated destruction or from an impaired re-
plenishment ofthe peripheral pool from precursors expanded
by IL-2, a possibility suggested by the expression of the IL-
2Rot chain on pro-B cells (11). So far, attempts at identify-
ing defects in T cell repertoire selection have yielded nega-
tive results (12) . With regard to a breakdown in peripheral
regulation, the delayed onset of immunopathology in germ-
free IL-2-deficient mice suggests that an antigen trigger is
required to drive the abnormal lymphoproliferation ob-
served (6). Since the oligoclonal repertoire ofathymic mice
allows alloreactive but not self-MHC-restricted T cell re-
sponses to environmental antigens (13-16), the IL-2 muta-
tion was introduced into nulnu mice to ask whether thy-
mus-processed T cells (with a diverse repertoire) are required
to initiate disease, including the destruction of B cells and
bone marrow cells. Furthermore, it remained to be formally
proven that lack of IL-2 expression in bone marrow-
derived cells suffices for the development of the IL-2 defi-
ciency syndrome. Therefore, recombination activator gene
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bone marrow from IL-2-'- mice were investigated for
signs of disease . Finally, the simultaneous transfer of IL-2+
and IL-2- bone marrow into RAG-2-deficient recipients
was used to address the question ofwhether autocrine pro-
duction of IL-2 is required for the control ofclonal expan-
sion or whether IL-2-producing or -dependent bystander
cells could interfere .
Materials and Methods
Mice .
￿
IL-2` mice from amixed C57BL/6/H1290LA back-
ground (4) were back-crossed for four generations to C57BL/6
mice . After mating with C57BL/6 nu/nu mice, IL-2` mice
were identified byPCR among the nude offspringofthe F2 gen-
eration . Euthymic IL-2"+ and IL-2+/- mice (which are pheno-
typically identical and will be referred to as IL-2+) were used as
controls . RAG-2` H-2b mice were originally generated by
Shinkai and colleagues (17) . These and B6 Ly5.2-congenic mice
(following the original nomenclature used for derivation of con-
genic strains and mAbs [18]) were kindly provided by Dr. H. R.
'Abbreviations used in this paper : BSS, balanced salt solution ; IEL, intraepi-
thelial lymphocytes ; RAG, recombination activator gene .
Figure 1.
￿
Influence of IL-2 deficiency on splenic ceHularity and T/13
cell content in euthymic and athymic mice. (A) Nucleated cells per spleen
recovered from euthymic IL-2+ (/), euthymic IL-2-/- (V), athymic IL-
2+ (O), and athymic IL-2`
(0) C57BL/6 mice . (B) Proportion of
splenic T cells (
￿
) and B cells (0 ) . Spleens from six to seven mice of
the groups indicated were analyzed for the fraction of Thy1- and B220-
expressing cells at 8-12 (euthymic mice) or 8-31 wk (athymic mice) .
Rodewald, Basel Institute for Immunology, Basel, Switzerland) .
All animals were bred in a barrier-sustained facility and were
found free ofcommon pathogens .
Preparation and Transfer of Cells.
￿
Cells from thymus, lymph
nodes, and spleen were prepared by grinding organs through a
stainless steel sieve into ice-cold balanced salt solution (BSS) . To
prepare intraepithelial lymphocytes, the small intestinewas opened
longitudinally in PBS, and Peyer's patches were removed . Small
pieces ofthe residual tissue were treated with Ca/Mg-free BSS/1
mM dithiothreitol for 20 min and with RPMI-1640/10% FCS
for 40 min at 37°C. Filtered cells were enriched for lymphocytes
by Percoll-gradient centrifugation . Hepatic mononuclear cells
were prepared by injecting PBS into the portal vein to remove
circulating cells from the liver before dissecting the animal . The
tissue was then crushed and washed twice with BSS . Lympho-
cytes were enriched by Ficoll-gradient centrifugation . Bone mar-
row was ejected from femur and tibia of hind legs by injecting
BSS . Bone marrow cellswere washed twice with BSS . In the case
of euthymic bone marrow donors, cells were further depleted of
Thy-1+ cells by a magnetism-activated cell sorter (MACS; Mil-
tenyi Biotec, Bergisch Gladbach, Germany) . To reconstitute
RAG-2-deficient mice, 2 X 10' BM cells, and for transfer into
nu/nu mice, 5 X 10' lymph node and spleen cells (1 : 1), were in-
jected intravenously .
Antibodies and Flow Cytometry .
￿
The following antibodies were
used : PE-conjugated anti-CD4 (clone H129.19; Becton Dickin-
son & Co ., Mountain View, CA), biotinylated or FITC-conju-
gated anti-CD8a (clone 53-6 .7 ; Boehringer Mannheim GmbH,
Mannheim, Germany), PE-conjugated anti-B220 (clone RA3-6B2 ;
Serva, Heidelberg, Germany), and FITC-conjugated anti-a[3Tcr
(clone H57-597 ; PharMingen, San Diego, CA) . . FITC-conju-
gated anti-Ly5 .1 (clone 104.2.1), and biotinylated anti-Ly5.2
(clone A20-1.7) (18) were kindly provided by Dr. H.R. Rodewald .
For two- or three-color flow cytometry, 2 X 10 5 cells in 0.1
ml PBS/0.1% BSA/0.02% sodium azide were stained with the
biotinylated antibody for 15 min on ice, washed, and incubated
for 15 min on ice with streptavidin redb'° (Life Technologies
GmbH, Eggenstein, Germany), the FITC-labeled mAb, and/or
the PE-conjugated mAb . All antibodies were used at saturating
concentrations . Flow cytometry was performedwith a FACScan°
flow cytometryr using Lysys II software (Becton Dickinson &
Co .) . Results are shown as log-log dot plots or as histograms .
Results
Thymus Dependence ofthe IL-2 Deficiency Syndrome .
￿
Both
the nu and the IL-2- mutation were bred to homozygosity
into the C57BL/6 background. Athymic IL-2-deficient
mice appeared healthy and, in contrast of their euthymic
littermates, showed no increased mortality . Even at >6 mo
of age, a time point where few euthymic IL-2-/- mice sur-
vive, none of the pathological alterations regularlyobserved
in IL-2` euthymic mice were found .
As shown in Fig . 1 A, cellularity of spleens remained
normal in athymic IL-2-'- mice, whereas their euthymic
littermates developed severe lymphadenopathy (not shown)
and splenomegaly, as previously described (5, 6) . More-
over, the loss of splenicB cells (Fig . 1 B) and mature B cells
from the bone marrow (Fig . 2), which follows initial poly-
clonal T andB cell activation in euthymic IL-2-~- mice,
was not observed in athymic IL-2-deficient mice, suggest-
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is crucial for B cell depletion. Similarly, infiltration of the
bone marrow with mature T cells, which is likely to play a
role in the loss ofB cells and development o£ anemia in eu-
thymic IL-2-'- mice, did not occur in IL-2-deficient athy-
mic mice (Fig. 2). Importantly, adoptive transfer ofperiph-
eral lymphocytes from IL-2-' - but not from IL-2+
C57BL/6 mice into athymic IL-2+ C57BL/6 mice, caused
T cell infiltration of the bone marrow (Fig. 2) and loss ofB
cells from bone marrow and spleen (not shown) .
One of the key symptoms of the IL-2 deficiency syn-
drome is inflammatory bowel disease with fatal outcome
(6) . The onset of colitis is preceded by an infiltration of the
gut epithelium with CD4 T cells, which represent a minor-
ity among normal intestinal intraepithelial lymphocytes
(IEL) . None of the athymic IL-2-' - mice developed overt
colitis, and even at the more sensitive level ofT cell subset
composition, no significant effects of the IL-2 mutation
were observed (Fig. 3). As shown above for the bone mar-
row, transfer of peripheral lymphocytes from euthymic IL-
2 -'- but not from IL-2+ mice resulted in infiltration of the
gut epithelium with CD4 T cells (Fig. 3).
In summary, development of the IL-2 deficiency syn-
drome depends on an intact thymus, indicating that destruc-
tion ofB cells and bone marrow cells as well as development
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ofcolitis are initiated by thymus-derived T cells, and that thy-
mus-independent T cell lineages do not mediate immune pa-
thology ifdeprived ofIL-2 . Furthermore, thymus-indepen-
dent cells expressing an intact IL-2 gene are unable to control
the abnormal activation of thymus-derived IL-2-'- T cells, at
least under the conditions of adoptive transfer used here.
Intrahepatic TCelts in Athymic IL-2-'- Mice.
￿
Aging athy-
mic mice contain variable numbers of T cells in their pe-
ripheral lymphoid organs, probably because of the expan-
sion of few T cell clones from a small number ofprecursors
(13-16) . Based on phenotypic similarities such as a reduced
level of TCR expression between hepatic T cells of euthy-
mic mice (19) and peripheral T cells found in athymic mice
(20, 21), the liver has been proposed as a site of extrathy-
mic T cell differentiation (19, 22). On the other hand, the
absence of RAG transcripts in the liver and influx of pre-
apoptotic activated peripheral T cells that acquire the phe-
notype of liver T cells has argued against this view and has
suggested a role for the liver in the elimination ofactivated
T cells (23, 24) . When T cell subsets were compared in
spleens and lymph nodes of IL-2+ and IL-2-'- C57BL/6
nu/nu mice, no differences beyond the individual variabil-
ity also found in IL-2+ athymic mice were observed (data
not shown) . Analyses of mononuclear cells from the livers
ofathymic mice, however, revealed a clear-cut effect ofIL-2
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Figure 2.
￿
T cell infiltration and B cell destruction in the bone marrow ofIL-2-deficient mice are thymus dependent. Flow cytometric analysis ofbone
marrow cells from IL-2+ andIL-2-/- euthymic (top) and athymic (center) C57BL/6 mice, and from IL-2+ athymic mice injected 6 wk previously with
5 X 101 peripheral lymphocytes from 4-wk-old IL-2+ or IL-2-/- C57BL/6 mice.
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Figure 3.
￿
Thymus dependence of CD4 T cell infiltration in the epithe-
lium ofthe small intestine ofIL-2-deficient mice. Flow cytometric analy-
sis ofintestinal IEL from IL-2+ and IL-2-1- euthymic (top) and athymic
(center) C57BL/6 mice, and from IL-2+ athymic mice injected 6 wk pre-
viously with 5 X 107 peripheral lymphocytes from 4-wk-old IL-2+ or IL-
2` C57BL/6 mice.
deficiency. Thus, the total number of recovered mononu-
clear cells (Table 1) and the frequency ofa/R T cells with a
reduced level of TCR expression (TCRint cells; Fig. 4 A),
which is characteristic of T cells in the liver, was stron
Table 1 .
￿
Number ofIntrahepatic Mononuclear Cells Isolatedfrom
the Livers ofIL-2+ and IL-2-1- Euthymic and Athymic Mice
y
*Mononuclear cells were isolated as described in Materials and Meth-
ods, and viable cells were counted by trypan blue exclusion.
increased in both euthymic and athymic C57BL/6 mice
carrying the IL-2 mutation compared with their IL-2+ lit-
termates. This increase in T cell number was primarily
caused by CD4-8 + cells (Fig. 4 B), ofwhich the frequency
among intrahepatic mononuclear cells increased 5-10-fold
in IL-2-deficient mice, irrespective of the presence ofa thy-
mus. It is unclear at the present time whether the expanded
CD4- 8+TCRint subset of intrahepatic T cells is caused by a
delayed elimination of immigrant peripheral T cells or by
local expansion (see Discussion).
Development of the IL-2 Deficiency Syndrome in RAG-2-
deficient Mice Reconstituted with IL-2+ and/or IL-2 - l- Bone
Marrow. To further analyze the role of the thymus in the
establishment of the IL-2 deficiency syndrome, RAG-2-
deficient mice were injected with bone marrow cells ex-
pressing or lacking an intact IL-2 gene. To ensure that the
bone marrow cells obtained from IL-2-deficient mice had
not already been damaged before transplantation, IL-2-
deficient athymic donors were chosen. As can be seen from
Table 2 and Fig. 5, transfer of both IL-2+ and IL-2 --
bone marrow cells led to a normal CD4/8 subset composi-
tion ofthe thymus in recipient RAG-2-1- mice when ani-
mals were analyzed 6 wk later. Whereas no pathologic al-
terations were observed in the control group that had
received IL-2+ bone marrow cells, all chimeras that had re-
ceived IL-2 -/- bone marrow exhibited lymphadenopathy
and splenomegaly, loss of red cells from the bone marrow,
and one animal died 5 wk after transfer. An elevated fre-
quency of CD4 T cells was found in five of five and T cell
infiltration of the bone marrow in four of five IL-2-'- -->
RAG-2` chimeras. Taken together with the results ob-
tained in athymic mice, this indicates that expression of the
IL-2 mutation in hematopoietic cells and a functional thy-
mus are required for the development of the IL-2 defi-
ciency syndrome.
To analyze whether the control of T cell activation that
breaks down in IL-2-deficient mice requires autocrine reg-
ulation by IL-2 or can be exerted by IL-2-expressing cells
(providing IL-2 in a paracrine fashion or acting as special-
ized suppressor cells), RAG-2-'- mice were coinjected
with 70% IL-2-' - and 30% Ly5.2-marked IL-2+ bone
marrow cells. When analyzed 6 wk after transfer, the ratio
of Ly5 .1- and Ly5.2-expressing lymphocytes was similar
(7 :3) in the thymus and in peripheral lymphoid organs of
the reconstituted animals. Importantly, three of four chi-
meras appeared healthy 6 wk after transfer, and only one
had an abnormally increased size and cellularity of spleen
and lymph nodes along with red cell destruction in the
bone marrow. Neither T cell infiltration nor red cell de-
struction were observed in the bone marrow of the re-
maining animals (Table 2 and Fig. 5). Overrepresentation
of CD4+ cells among intestinal IEL was found in one addi-
tional mouse, which, however, remained free ofdiarrhea or
overt colitis. These results show that to a large extent, T
cells capable of producing IL-2 are able to contain the dys-
regulated activation of IL-2-deficient T cells that leads to
the development of the IL-2 deficiency syndrome in RAG-
2 -1- mice restored with IL-2-1- bone marrow cells.
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Mouse Age
wk
Mononuclear cells/
liver*
C57BL/6 IL-2+ 3 1 .0 X 10,
C57BL/6 IL-2+ 3 0.7 X 105
C57BL/6 IL-2` 3 1 .2 X 106
C57BL/6 IL-2` 3 2.6 X 106
C57BL/6 nu/nu IL-2+ 22 1 .4 X 105
C57BL/6 nu/nu IL-2+ 30 2.0 X 105
C57BL/6 nu/nu IL-2-/- 22 6.0 X 105
C5713L/6 nu/nu
IL-2`
30 7.2 X 105B
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The hallmark of the inflammatory and autoimmune
manifestations of the mouse IL-2 deficiency syndrome is a
hyperactivation of T cells, which precedes all other symp-
toms described above and, according to the present results,
is likely to be the key event in the development of immune
pathology. Thus, athymic mice carrying the IL-2 mutation
remain free of bone marrow atrophy and red cell destruc-
tion, maintain normal B cell numbers, and do not develop
colitis. Consequently, a direct effect of IL-2 deficiency on
the survival of bone marrow stem cells and on the genera-
tion and maintenance of their B cell and erythrocyte prog-
eny can be excluded. Furthermore, the thymus-indepen-
dent T cell lineages originating in the gut epithelium do not
mediate the inflammatory response found at that site in eu-
thymic IL-2-deficient animals. In contrast, peripheral T
cells transferred into nude mice from IL-2-1- donors infil-
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Figure 4.
￿
Increase of TCR'"t
CD4-8+ intrahepatic lympho
C57BL/6
￿
cytes in both euthymic and athy-
mic IL-2-1- mice. (A) TCR ex-
pression on mononuclear cells
isolated from the lymph nodes
(top) and liver (center) of 3-wk-
old euthymic IL-2+ and IL-2--
mice, and on intrahepatic mono-
nuclear cells from 22-wk-old
athymic IL-2+ and IL-2-' - mice
(bottom). (B) Expression of CD4
and/or CDS on TCR+ intrahe-
patic lymphocytes. (C CD4/
CD8 distribution of all intrahe-
patic mononuclear cells.
C57BL/6
nu/nu
trate the gut and the bone marrow, supporting the conclu-
sion that thymus-derived T cells are responsible for disease
development.
The only difference detected in IL-2-deficient athymic
mice compared with their IL-2+ littermates was a numeric
increase in hepatic T cells that displayed the TCR'°` phe-
notype found on the majority of hepatic T cells in normal
mice and on T cells in both lymphoid organs and liver of
athymic mice. This increase was mainly caused by CD4-8+
cells, which were also severalfold expanded in the liver of
euthymic IL-2-deficient mice compared with IL-2+ con-
trols. We have previously reported that among the small
subset of ot/(3TCR'°tIL-2R(3+ thymocytes, which in nor-
mal mice are predominantly CD4-8- , IL-2 deficiency also
causes a marked skewing toward the CD4-8+ phenotype
(25). Such oc/(3TCR'n1IL-2R(3+ T cells in the thymus andRAG-2-'- mice were injected intravenously with a total of 2 X 107 bone marrow cells (for details see legend to Fig. 5) and analyzed 6 wk after
transfer.
*Morethan twice the size oforgans in age-matched C57BL/6 mice.
$Only whitecells in bone marrow.
§As determined by flow cytometry using fluorescent TCR- and CD4-specific mAbs.
a/(3TCR'nt cells in the liver could either represent a dis-
tinct lineage or the end stage ofclonally expanded cells be-
fore apoptosis. In the former scenario, the development of
the CD4-8+ subset of this lineage might be favored by the
absence of IL-2; in the latter, IL-2 deficiency may retard
the process of elimination of clonally expanded CD4- 8+
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cells more severely than that of other T cells. This view is
compatible with recent evidence showing that the CD4-8-
o/R T cells present in the thymus (26) and those accumu-
lating in Fas-deficient Ipr/lpr mice are predominantly MHC
class I dependent and, by implication, may be derived from
the CD8lineage (27-29). Furthermore, activatedTCR-trans-
thymus
BM
CD8 (loglo fluorescence)
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Figure 5. IL-2+ cells suppress
bone marrow infiltration by IL-2-'-
CD4 T cells. Thymocytes (top) and
bone marrow cells (bottom) from
RAG-2-~- mice injected 6 wk pre-
viouslywith bone marrow cellsfrom
the following sources: C57BL/6,
C57BL/6 nu/nu IL-2-/- , or
C57BL/6 nu/nu IL-2-/- (70%) and
B6Ly5.2 (30%). Single chimeras
were analyzed by two-color, double
chimeras by three-color flow cytom-
etry and gated on Ly5.1+ lympho-
cytesto detect progeny oftheIL-2-/-
bone marrow.
Table 2 . Phenotype
Intact IL-2 gene
in bone marrow
ofRAG-2-'- Mice Reconstituted
Splenomegaly/
lymphadenopathy*
with IL-2+ and/or
Red cell
destruction$
IL-2-1- Bone Marrow Cells
% T cellsin
bone marrow§
% CD4
in IEL§ Other
+ - - 3.1 10.5 -
+ - - 9.3 7.3 -
+ - - 6.2 8.4 -
- + + 3.0 20.1 Diarrhea
- + + 36.2 20.7 -
- + + 30.0 16.4 -
- + + 52.9 12 .6 -
- + + 18.3 19 .3 -
- ? ? ? ? Dead
+,- (3:7) - - 3.8 8.4 -
+,- (3:7) + + 4.8 24.0 -
+,- (3:7) - - 8.3 18 .4 -
+,- (3:7) - - 5.0 8.8 -genic CD8 T cells downregulate CD8 before undergoing
apoptosis in the liver (24) . Thus, IL-2 deficiency may re-
tard the conversion ofactivated CD8 T cells to CD4-8- T
cells and their subsequent elimination by apoptosis, result-
ing in an accumulation of the intermediate CD8+TCR'°t
phenotype in the liver and a shift from CD4-8- to CD4-8+
cells among IL-2RR+ thymocytes.
The resemblance of the IL-2 deficiency syndrome to
some features of GVHD has prompted an earlier search for
a defect in negative repertoire selection in these animals
(12). Neither central deletion of V(3-defined T cell subsets
by endogenous superantigens nor its acute induction by
peptide administration in an MHC class I-restricted TCR-
transgenic model, however, revealed any obvious effects of
the IL-2 mutation. We thus favor the view that disease is
initiated by an uncontrolled peripheral activation of T cells
with a "normal" repertoire, rather than an increased escape
of autoreactive T cells from intrathymic deletion. This un-
controlled activation is most likely driven by environmen-
tal antigens since athymic mice, which do contain functional
T cells, albeit with a very restricted repertoire (13-16), do
not develop disease. This conclusion is further supported
by the delayed onset ofinflammatory bowel disease in mice
with a reduced antigenic environment (6) .
As shown by cotransfer o£ IL-2-1- and IL-2+ bone mar-
row into RAG-2-deficient mice, the simultaneous pres-
ence of lymphocytes with an intact IL-2 gene can greatly
attenuate the development ofthe IL-2 deficiency syndrome.
Therefore, IL-2-deficient mice either lack a specialized im-
munoregulatory cell population that depends on IL-2 for
its development or function, or IL-2 provided in an auto-
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crine or paracrine fashion is required for the termination of
clonal expansion by apoptosis, as has been suggested by
Lenardo (10). Indeed, recent results indicate that activated
T cells from IL-2-deficient mice are more resistant to Fas-
induced apoptosis than those from IL-2 wild-type mice
(30). On the other hand, IL-2 could also be required for
the induction of cytotoxic activity in CD8 T cells, which,
as suggested by recent experiments by Jiang and colleagues
(31), might eliminate clonally expanded CD4 T cells (which
are the main population that expands in peripheral lymphoid
organs ofIL-2-deficient mice). Although antiviral CTL re-
sponses have been observed in IL-2-deficient mice (32),
this seems to be a viable explanation since in a TCR-trans-
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